In this issue:
LABA/LAMA vs LABA/ICS for COPD in real-world clinical practice
Pharmacist-led intervention for COPD patients
Predictors of response to maintenance azithromycin
A COPD prediction model identifies undiagnosed at-risk patients
Ambient fine particulate matter and COPD
HFNC oxygen therapy in COPD patients with hypercapnic ARF
LAMA/LABA therapy improves dynamic lung hyperinflation
External validation and recalculation of the CODEX index
Low BMI is associated with higher risk of COPD
Human rhinovirus impairs the innate immune response to bacteria in COPD
Please login below to download this issue (PDF)